✦ LIBER ✦

Cancer cell senescence: a new frontier in drug development

✍ Scribed by Claire J. Cairney; Alan E. Bilsland; T.R. Jeffry Evans; Jon Roffey; Dorothy C. Bennett; Masashi Narita; Christopher J. Torrance; W. Nicol Keith

Book ID: 113569466
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 701 KB
Volume: 17
Category: Article
ISSN: 1359-6446
DOI: 10.1016/j.drudis.2012.01.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apoptosis, senescence and cancer (cancer

Apoptosis, senescence and cancer (cancer drug discovery and development)

✍ Young, A 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 39 KB

New Frontiers in Renal Cell Cancer

✍ Manfred Johannsen; Jan Roigas; Stefan A. Loening 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

New directions in cancer drug developmen

New directions in cancer drug development

✍ Joanne Clough 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 24 KB

New drug development in metastatic prost

New drug development in metastatic prostate cancer

✍ Andrew J. Armstrong; Daniel J. George 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 285 KB

New Drugs in the Frontier of Treatment o

New Drugs in the Frontier of Treatment of Metastatic Colorectal Cancer

✍ Christina Wu, Richard M. Goldberg 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 240 KB

New frontiers in cell line development:

New frontiers in cell line development: challenges for biosimilars

✍ Jeff Jia Cheng Hou; Joe Codamo; Warren Pilbrough; Benjamin Hughes; Peter P Gray; 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 145 KB

## Abstract Worldwide sales of biologic drugs exceeded US$ 92 billion in 2009. With many biopharmaceutical patents expiring over the next decade, a wave of second‐generation or ‘follow‐on’ biologics will be vying for market share and regulatory approval. Patents cover not only the drugs, but also t